Cargando…
Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma
Gastroenteropancreatic neuroendocrine carcinoma (GEP-NEC) is a poorly understood disease with limited treatment options. A better understanding of this disease would greatly benefit from the availability of representative preclinical models. Here, we present the potential of tumor organoids, three-d...
Autores principales: | Dijkstra, Krijn K., van den Berg, José G., Weeber, Fleur, van de Haar, Joris, Velds, Arno, Kaing, Sovann, Peters, Dennis D. G. C., Eskens, Ferry A. L. M., de Groot, Derk-Jan A., Tesselaar, Margot E. T., Voest, Emile E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991829/ https://www.ncbi.nlm.nih.gov/pubmed/33776923 http://dx.doi.org/10.3389/fendo.2021.627819 |
Ejemplares similares
-
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial
por: Levy, Sonja, et al.
Publicado: (2022) -
Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine
por: van de Haar, Joris, et al.
Publicado: (2019) -
Prospective experimental treatment of colorectal cancer patients based on organoid drug responses
por: Ooft, S.N., et al.
Publicado: (2021) -
The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets
por: van Riet, Job, et al.
Publicado: (2021) -
Nutritional and vitamin status in patients with neuroendocrine neoplasms
por: Clement, Dominique SVM, et al.
Publicado: (2019)